Advertisement
U.S. markets close in 5 hours 59 minutes
  • S&P 500

    5,138.08
    -11.34 (-0.22%)
     
  • Dow 30

    38,855.53
    +65.10 (+0.17%)
     
  • Nasdaq

    15,994.19
    -109.26 (-0.68%)
     
  • Russell 2000

    2,017.91
    -6.82 (-0.34%)
     
  • Crude Oil

    82.92
    +0.20 (+0.24%)
     
  • Gold

    2,154.90
    -9.40 (-0.43%)
     
  • Silver

    25.05
    -0.22 (-0.87%)
     
  • EUR/USD

    1.0859
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    4.3160
    -0.0240 (-0.55%)
     
  • GBP/USD

    1.2700
    -0.0029 (-0.23%)
     
  • USD/JPY

    150.7070
    +1.6090 (+1.08%)
     
  • Bitcoin USD

    63,541.82
    -3,971.87 (-5.88%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,725.07
    +2.52 (+0.03%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Earnings Outlook For Adtran

On Tuesday, Adtran (NASDAQ: ADTN) will release its latest earnings report. Benzinga's outlook for Adtran is included in the following report.

Earnings and Revenue

Analysts are predicting Adtran will report a loss of 32 cents per share on revenue of $127.55 million.

View more earnings on ADTN

Adtran reported a profit of 30 cents when it published results during the same quarter last year. Sales in that period totaled $184.67 million. If the company were to match the consensus estimate, earnings would be down 206.67 percent. Revenue would be down 30.93 percent on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:

Quarter

Q1 2018

Q4 2017

Q3 2017

Q2 2017

EPS Estimate

-0.18

0.07

0.26

0.19

EPS Actual

-0.29

0.05

0.37

0.3

Stock Performance

Over the last 52-week period, shares are down 21.57 percent. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release. Over the past 90 days, analysts have generally adjusted their estimates lower for EPS and revenues. The most common rating from analysts on Adtran stock is a Sell. The strength of this rating has maintained conviction over the past three months.

See more from Benzinga

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement